The NUP98::TNRC18 fusion gene was first reported in 2022 in the largest multicenter AML cohort in China.14 In this case, we identified and extensively characterized a novel NUP98::TNRC18 fusion transcript in a patient with de novo AML. The gene discussed is NUP98; the disease is acute myeloid leukemia.